IQVIA HOLDINGS
IQV Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-02-10
2025-02-12
PATEL BHAVIK
President, Commercial Solution...
F - Tax
Common Stock
-108
$207.00
-22,356
1
$27.14B
2025-02-10
2025-02-12
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-179
$207.00
-37,053
1
$27.14B
2025-02-10
2025-02-12
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-141
$207.00
-29,187
1
$27.14B
2025-02-10
2025-02-12
BOUSBIB ARI
Chairman, Chief Executive Offi...
M - Exercise
Stock Appreciation Right
-40,000
$65.00
-2.60M
1
$27.14B
2025-02-10
2025-02-12
BOUSBIB ARI
Chairman, Chief Executive Offi...
M - Exercise
Common Stock
40,000
$65.00
2.60M
1
$27.14B
2025-02-10
2025-02-12
BOUSBIB ARI
Chairman, Chief Executive Offi...
D - Sale to Issuer
Common Stock
-26,585
$207.00
-5.50M
1
$27.14B
2025-02-10
2025-02-12
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-3,335
$207.00
-690K
1
$27.14B
2025-02-10
2025-02-12
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-907
$207.00
-188K
1
$27.14B
2025-02-10
2025-02-12
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-16
$207.00
-3,312
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-176
$203.00
-35,728
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
F - Tax
Common Stock
-612
$203.00
-124K
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-605
$203.00
-123K
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-479
$203.00
-97,237
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Stock Appreciation Right
10,534
$0.00
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Common Stock
1,299
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,201
$203.00
-447K
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-176
$203.00
-35,728
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
F - Tax
Common Stock
-612
$203.00
-124K
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-479
$203.00
-97,237
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Stock Appreciation Right
2,633
$0.00
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Common Stock
2,898
$0.00
2
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
73,741
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
31,603
$0.00
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
14,045
$0.00
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Stock Appreciation Right
10,534
$0.00
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Common Stock
1,299
$0.00
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
2,356
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
24,580
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
1,571
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-10,500
$203.00
-2.13M
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,201
$203.00
-447K
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
14,045
$0.00
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
2,356
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
24,580
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
1,571
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-10,500
$203.00
-2.13M
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-605
$203.00
-123K
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
14,045
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
73,741
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
22,000
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
31,603
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
6,286
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
73,741
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
22,000
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
22,000
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
31,603
$0.00
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
6,286
$0.00
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Stock Appreciation Right
2,633
$0.00
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Common Stock
2,898
$0.00
2
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
6,286
$0.00
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Stock Appreciation Right
2,633
$0.00
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Stock Appreciation Right
10,534
$0.00
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
A - Grant
Common Stock
1,299
$0.00
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Common Stock
2,898
$0.00
2
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
2,356
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
24,580
$0.00
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
1,571
$0.00
1
$27.14B
2025-01-28
2025-01-30
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-10,500
$203.00
-2.13M
1
$27.14B
2025-01-28
2025-01-30
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,201
$203.00
-447K
1
$27.14B
2025-01-28
2025-01-30
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-176
$203.00
-35,728
1
$27.14B
2025-01-28
2025-01-30
PATEL BHAVIK
President, Commercial Solution...
F - Tax
Common Stock
-612
$203.00
-124K
1
$27.14B
2025-01-28
2025-01-30
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-605
$203.00
-123K
1
$27.14B
2025-01-28
2025-01-30
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-479
$203.00
-97,237
1
$27.14B
2024-08-27
2024-08-29
SHERBET ERIC
Executive Vice President, Gene...
S - Sale
Common Stock
-1,300
$246.00
-320K
1
$27.14B
2024-07-28
2024-07-30
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-35
$240.00
-8,400
1
$27.14B
2024-07-28
2024-07-30
PATEL BHAVIK
President, Commercial Solution...
F - Tax
Common Stock
-83
$240.00
-19,920
1
$27.14B
2024-03-01
2024-03-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
M - Exercise
Stock Appreciation Right
-42,847
$65.00
-2.79M
1
$27.14B
2024-03-01
2024-03-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
M - Exercise
Common Stock
42,847
$65.00
2.79M
1
$27.14B
2024-03-01
2024-03-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-31,678
$251.00
-7.95M
2
$27.14B
2024-03-01
2024-03-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
D - Sale to Issuer
Common Stock
-11,169
$250.00
-2.79M
1
$27.14B
2024-02-29
2024-03-04
STAUB RICHARD
President, Research & Developm...
S - Sale
Common Stock
-14,100
$248.00
-3.50M
3
$27.14B
2024-02-28
2024-03-01
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-8,607
$250.00
-2.15M
2
$27.14B
2024-02-28
2024-03-01
KNIGHTLY KEVIN
President, Corporate Strategy ...
D - Sale to Issuer
Common Stock
-4,599
$251.00
-1.15M
1
$27.14B
2024-02-28
2024-03-01
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Stock Appreciation Right
-13,206
$87.00
-1.15M
2
$27.14B
2024-02-28
2024-03-01
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Common Stock
13,206
$87.00
1.15M
2
$27.14B
2024-02-16
2024-02-21
KNIGHTLY KEVIN
President, Corporate Strategy ...
D - Sale to Issuer
Common Stock
-3,941
$241.00
-950K
1
$27.14B
2024-02-16
2024-02-21
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Stock Appreciation Right
-12,149
$78.00
-948K
1
$27.14B
2024-02-16
2024-02-21
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Common Stock
12,149
$78.00
948K
1
$27.14B
2024-02-16
2024-02-21
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-13,468
$241.00
-3.25M
4
$27.14B
2024-02-16
2024-02-21
SHERBET ERIC
Executive Vice President, Gene...
S - Sale
Common Stock
-1,000
$242.00
-242K
1
$27.14B
2024-02-10
2024-02-13
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-3,335
$218.00
-727K
1
$27.14B
2024-02-10
2024-02-13
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-215
$218.00
-46,870
1
$27.14B
2024-02-10
2024-02-13
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-289
$218.00
-63,002
1
$27.14B
2024-02-10
2024-02-13
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-303
$218.00
-66,054
1
$27.14B
2024-02-10
2024-02-13
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-15
$218.00
-3,270
1
$27.14B
2024-02-10
2024-02-13
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-907
$218.00
-198K
1
$27.14B
2024-02-09
2024-02-13
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-353
$218.00
-76,954
1
$27.14B
2024-02-09
2024-02-13
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-3,909
$218.00
-852K
1
$27.14B
2024-02-09
2024-02-13
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-1,033
$218.00
-225K
1
$27.14B
2024-02-09
2024-02-13
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-61
$218.00
-13,298
1
$27.14B
2024-02-09
2024-02-13
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-311
$218.00
-67,798
1
$27.14B
2024-02-09
2024-02-13
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-281
$218.00
-61,258
1
$27.14B
2024-02-07
2024-02-08
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Stock Appreciation Right
1,726
$0.00
1
$27.14B
2024-02-07
2024-02-08
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
20,719
$0.00
1
$27.14B
2024-02-07
2024-02-08
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
72,517
$0.00
1
$27.14B
2024-02-07
2024-02-08
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
13,812
$0.00
1
$27.14B
2024-02-07
2024-02-08
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
9,496
$0.00
1
$27.14B
2024-02-07
2024-02-08
KNIGHTLY KEVIN
President, Corporate Strategy ...
A - Grant
Stock Appreciation Right
6,906
$0.00
1
$27.14B
2024-02-06
2024-02-08
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-3,148
$215.00
-677K
1
$27.14B
2024-02-06
2024-02-08
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-2,372
$215.00
-510K
1
$27.14B
2024-02-06
2024-02-08
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-2,688
$215.00
-578K
1
$27.14B
2024-02-06
2024-02-08
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
8,690
$0.00
1
$27.14B
2024-02-06
2024-02-08
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
86,912
$0.00
1
$27.14B
2024-02-06
2024-02-08
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-10,514
$215.00
-2.26M
1
$27.14B
2024-02-06
2024-02-08
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-43,677
$215.00
-9.39M
1
$27.14B
2024-02-06
2024-02-08
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
24,141
$0.00
1
$27.14B
2024-02-06
2024-02-08
KNIGHTLY KEVIN
President, Corporate Strategy ...
A - Grant
Common Stock
7,241
$0.00
1
$27.14B
2024-02-06
2024-02-08
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
7,725
$0.00
1
$27.14B
2023-12-01
2023-12-05
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Common Stock
18,491
$62.00
1.15M
2
$27.14B
2023-12-01
2023-12-05
KNIGHTLY KEVIN
President, Corporate Strategy ...
D - Sale to Issuer
Common Stock
-5,374
$214.00
-1.15M
1
$27.14B
2023-12-01
2023-12-05
KNIGHTLY KEVIN
President, Corporate Strategy ...
M - Exercise
Stock Appreciation Right
-18,491
$62.00
-1.15M
2
$27.14B
2023-12-01
2023-12-05
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-13,117
$214.00
-2.81M
3
$27.14B
2023-09-19
2023-09-21
PANAGOS CONSTANTINOS
President, Research & Developm...
D - Sale to Issuer
Common Stock
-18,767
$209.00
-3.92M
1
$27.14B
2023-09-19
2023-09-21
PANAGOS CONSTANTINOS
President, Research & Developm...
M - Exercise
Stock Appreciation Right
-26,186
$0.00
4
$27.14B
2023-09-19
2023-09-21
PANAGOS CONSTANTINOS
President, Research & Developm...
M - Exercise
Common Stock
26,186
$149.00
3.90M
4
$27.14B
2023-09-19
2023-09-21
PANAGOS CONSTANTINOS
President, Research & Developm...
S - Sale
Common Stock
-27,317
$209.00
-5.71M
2
$27.14B
2023-08-03
2023-08-07
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,588
$216.00
-559K
1
$27.14B
2023-07-28
2023-08-01
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-35
$226.00
-7,910
1
$27.14B
2023-06-05
2023-06-07
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-5,820
$202.00
-1.18M
1
$27.14B
2023-05-26
2023-05-31
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-1
$199.00
-199
1
$27.14B
2023-05-25
2023-05-25
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
-5,821
$198.00
-1.15M
1
$27.14B
2023-02-16
2023-02-17
KNIGHTLY KEVIN
President, Corporate Strategy ...
S - Sale
Common Stock
-4,446
$226.00
-1.00M
2
$27.14B
2023-02-14
2023-02-15
SHERBET ERIC
Executive Vice President, Gene...
S - Sale
Common Stock
-1,000
$230.00
-230K
1
$27.14B
2023-02-13
2023-02-15
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
20,600
$0.00
1
$27.14B
2023-02-13
2023-02-15
CHEROFSKY KERIANN
SVP, Corporate Controller
A - Grant
Stock Appreciation Right
1,373
$0.00
1
$27.14B
2023-02-13
2023-02-15
KNIGHTLY KEVIN
President, Corporate Strategy ...
A - Grant
Stock Appreciation Right
6,866
$0.00
1
$27.14B
2023-02-13
2023-02-15
PANAGOS CONSTANTINOS
President, Research & Developm...
A - Grant
Stock Appreciation Right
10,300
$0.00
1
$27.14B
2023-02-13
2023-02-15
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
72,102
$0.00
1
$27.14B
2023-02-13
2023-02-15
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
8,583
$0.00
1
$27.14B
2023-02-11
2023-02-13
PANAGOS CONSTANTINOS
President, Research & Developm...
F - Tax
Common Stock
-1,382
$223.00
-308K
1
$27.14B
2023-02-11
2023-02-13
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-54
$223.00
-12,042
1
$27.14B
2023-02-10
2023-02-13
PANAGOS CONSTANTINOS
President, Research & Developm...
F - Tax
Common Stock
-289
$223.00
-64,447
1
$27.14B
2023-02-10
2023-02-13
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-3,496
$223.00
-780K
1
$27.14B
2023-02-10
2023-02-13
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-15
$223.00
-3,345
1
$27.14B
2023-02-10
2023-02-13
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-614
$223.00
-137K
1
$27.14B
2023-02-10
2023-02-13
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-326
$223.00
-72,698
1
$27.14B
2023-02-10
2023-02-13
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-303
$223.00
-67,569
1
$27.14B
2023-02-09
2023-02-13
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-311
$230.00
-71,530
1
$27.14B
2023-02-09
2023-02-13
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-4,097
$230.00
-942K
1
$27.14B
2023-02-09
2023-02-13
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-717
$230.00
-165K
1
$27.14B
2023-02-09
2023-02-13
CHEROFSKY KERIANN
SVP, Corporate Controller
F - Tax
Common Stock
-60
$230.00
-13,800
1
$27.14B
2023-02-09
2023-02-13
PANAGOS CONSTANTINOS
President, Research & Developm...
F - Tax
Common Stock
-2,612
$230.00
-601K
1
$27.14B
2023-02-09
2023-02-13
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-317
$230.00
-72,910
1
$27.14B
2023-02-07
2023-02-09
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
8,745
$0.00
1
$27.14B
2023-02-07
2023-02-09
PANAGOS CONSTANTINOS
President, Research & Developm...
A - Grant
Common Stock
4,371
$0.00
1
$27.14B
2023-02-07
2023-02-09
KNIGHTLY KEVIN
President, Corporate Strategy ...
A - Grant
Common Stock
5,829
$0.00
1
$27.14B
2023-02-07
2023-02-09
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-3,267
$236.00
-771K
1
$27.14B
2023-02-07
2023-02-09
PANAGOS CONSTANTINOS
President, Research & Developm...
F - Tax
Common Stock
-1,341
$236.00
-316K
1
$27.14B
2023-02-07
2023-02-09
KNIGHTLY KEVIN
President, Corporate Strategy ...
F - Tax
Common Stock
-2,090
$236.00
-493K
1
$27.14B
2023-02-07
2023-02-09
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
87,459
$0.00
1
$27.14B
2023-02-07
2023-02-09
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-44,014
$236.00
-10M
1
$27.14B
2022-11-01
2022-11-03
PANAGOS CONSTANTINOS
President, Research & Developm...
F - Tax
Common Stock
-1,818
$209.00
-380K
1
$27.14B
2022-08-03
2022-08-05
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,588
$233.00
-603K
1
$27.14B
2021-10-25
2022-02-17
BRUEHLMAN RONALD
EVP & Chief Financial Officer
S - Sale
Common Stock
-4
$257.00
-1,028
1
$27.14B
2021-09-23
2022-02-17
BRUEHLMAN RONALD
EVP & Chief Financial Officer
P - Purchase
Common Stock
4
$263.00
1,052
1
$27.14B
2022-02-10
2022-02-14
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
76,472
$0.00
1
$27.14B
2022-02-10
2022-02-14
KORAKIS EMMANUEL
SVP, Controller & Treasurer
A - Grant
Stock Appreciation Right
2,184
$0.00
1
$27.14B
2022-02-10
2022-02-14
KORAKIS EMMANUEL
SVP, Controller & Treasurer
A - Grant
Common Stock
586
$0.00
1
$27.14B
2022-02-10
2022-02-14
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
8,193
$0.00
1
$27.14B
2022-02-10
2022-02-14
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
2,200
$0.00
1
$27.14B
2022-02-10
2022-02-14
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
5,462
$0.00
1
$27.14B
2022-02-10
2022-02-14
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
1,467
$0.00
1
$27.14B
2022-02-10
2022-02-14
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
20,542
$0.00
1
$27.14B
2022-02-10
2022-02-14
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
21,849
$0.00
1
$27.14B
2022-02-10
2022-02-14
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
5,869
$0.00
1
$27.14B
2022-02-10
2022-02-14
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Stock Appreciation Right
7,283
$0.00
1
$27.14B
2022-02-10
2022-02-14
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Common Stock
1,956
$0.00
1
$27.14B
2021-07-20
2022-02-14
BRUEHLMAN RONALD
EVP & Chief Financial Officer
P - Purchase
Common Stock
13
$245.00
3,185
1
$27.14B
2022-02-09
2022-02-11
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
91,142
$0.00
1
$27.14B
2022-02-09
2022-02-11
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Common Stock
9,114
$0.00
1
$27.14B
2022-02-09
2022-02-11
KORAKIS EMMANUEL
SVP, Controller & Treasurer
A - Grant
Common Stock
1,822
$0.00
1
$27.14B
2022-02-09
2022-02-11
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
9,114
$0.00
1
$27.14B
2022-02-09
2022-02-11
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
9,114
$0.00
1
$27.14B
2022-02-09
2022-02-11
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-50,039
$256.00
-13M
1
$27.14B
2022-02-09
2022-02-11
KNIGHTLY KEVIN
President, Technology & Commer...
F - Tax
Common Stock
-3,961
$256.00
-1.01M
1
$27.14B
2022-02-09
2022-02-11
KORAKIS EMMANUEL
SVP, Controller & Treasurer
F - Tax
Common Stock
-758
$256.00
-194K
1
$27.14B
2022-02-09
2022-02-11
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-3,788
$256.00
-970K
1
$27.14B
2022-02-09
2022-02-11
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-3,834
$256.00
-982K
1
$27.14B
2022-02-09
2022-02-11
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-705
$256.00
-180K
1
$27.14B
2021-08-16
2021-08-18
KNIGHTLY KEVIN
President, Technology & Commer...
S - Sale
Common Stock
-6,055
$250.00
-1.51M
1
$27.14B
2021-08-03
2021-08-05
BRUEHLMAN RONALD
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,391
$0.00
1
$27.14B
2021-02-09
2021-02-11
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
12,207
$0.00
2
$27.14B
2021-02-09
2021-02-11
KNIGHTLY KEVIN
President, Technology & Commer...
F - Tax
Common Stock
-3,745
$184.00
-689K
1
$27.14B
2021-02-09
2021-02-11
KORAKIS EMMANUEL
Sr. Vice President, Controller
F - Tax
Common Stock
-565
$184.00
-104K
1
$27.14B
2021-02-09
2021-02-11
SHERBET ERIC
Executive Vice President, Gene...
F - Tax
Common Stock
-1,893
$184.00
-348K
1
$27.14B
2021-02-09
2021-02-11
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-3,583
$184.00
-659K
1
$27.14B
2021-02-09
2021-02-11
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Stock Appreciation Right
96,124
$0.00
1
$27.14B
2021-02-09
2021-02-11
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
97,577
$0.00
2
$27.14B
2021-02-09
2021-02-11
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Stock Appreciation Right
26,701
$0.00
1
$27.14B
2021-02-09
2021-02-11
BRUEHLMAN RONALD
EVP & Chief Financial Officer
A - Grant
Common Stock
6,687
$0.00
1
$27.14B
2021-02-09
2021-02-11
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Stock Appreciation Right
8,010
$0.00
1
$27.14B
2021-02-09
2021-02-11
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Common Stock
11,806
$0.00
2
$27.14B
2021-02-09
2021-02-11
KORAKIS EMMANUEL
Sr. Vice President, Controller
A - Grant
Stock Appreciation Right
2,670
$0.00
1
$27.14B
2021-02-09
2021-02-11
KORAKIS EMMANUEL
Sr. Vice President, Controller
A - Grant
Common Stock
2,242
$0.00
2
$27.14B
2021-02-09
2021-02-11
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
8,544
$0.00
1
$27.14B
2021-02-09
2021-02-11
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Common Stock
7,585
$0.00
2
$27.14B
2021-02-09
2021-02-11
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
9,612
$0.00
1
$27.14B
2021-02-09
2021-02-11
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-35,995
$184.00
-6.62M
1
$27.14B
2021-02-02
2021-02-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
F - Tax
Common Stock
-61,522
$184.00
-11M
1
$27.14B
2020-12-10
2021-02-04
BRUEHLMAN RONALD
EVP & Chief Financial Officer
G - Gift
Common Stock
-60
$0.00
1
$27.14B
2020-12-09
2021-02-04
BRUEHLMAN RONALD
EVP & Chief Financial Officer
G - Gift
Common Stock
-60
$0.00
1
$27.14B
2020-10-28
2020-10-30
KORAKIS EMMANUEL
Sr. Vice President, Controller
A - Grant
Common Stock
1,605
$0.00
1
$27.14B
2020-10-12
2020-10-14
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-69,120
$170.00
-12M
1
$27.14B
2020-10-12
2020-10-14
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
69,120
$8.00
553K
1
$27.14B
2020-10-12
2020-10-14
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-69,120
$0.00
1
$27.14B
2020-09-15
2020-09-17
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-46,080
$164.00
-7.56M
1
$27.14B
2020-09-15
2020-09-17
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
46,080
$8.00
369K
1
$27.14B
2020-09-15
2020-09-17
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-46,080
$0.00
1
$27.14B
2020-08-14
2020-08-18
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
69,120
$8.00
553K
1
$27.14B
2020-08-14
2020-08-18
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-69,120
$0.00
1
$27.14B
2020-08-14
2020-08-18
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-69,120
$162.00
-11M
1
$27.14B
2020-08-07
2020-08-11
STAUB RICHARD
President, Research & Developm...
D - Sale to Issuer
Common Stock
-13,523
$161.00
-2.18M
1
$27.14B
2020-08-07
2020-08-11
STAUB RICHARD
President, Research & Developm...
S - Sale
Common Stock
-20,367
$160.00
-3.26M
2
$27.14B
2020-08-07
2020-08-11
STAUB RICHARD
President, Research & Developm...
M - Exercise
Employee Stock Option (Right to Buy)
-13,483
$0.00
3
$27.14B
2020-08-07
2020-08-11
STAUB RICHARD
President, Research & Developm...
M - Exercise
Stock Appreciation Right
-20,407
$0.00
2
$27.14B
2020-08-07
2020-08-11
STAUB RICHARD
President, Research & Developm...
M - Exercise
Common Stock
33,890
$87.00
2.95M
5
$27.14B
2020-08-04
2020-08-05
BRUEHLMAN RONALD
EVP & interim Chief Financial ...
P - Purchase
Common Stock
10,000
$160.00
1.60M
1
$27.14B
2020-08-03
2020-08-05
BRUEHLMAN RONALD
EVP & interim Chief Financial ...
A - Grant
Common Stock
16,751
$0.00
1
$27.14B
2020-07-28
2020-07-29
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
S - Sale
Common Stock
-2.92M
$159.00
-464M
1
$27.14B
2020-07-22
2020-07-24
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-46,080
$160.00
-7.37M
1
$27.14B
2020-07-22
2020-07-24
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
46,080
$8.00
369K
1
$27.14B
2020-07-22
2020-07-24
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-46,080
$0.00
1
$27.14B
2020-06-02
2020-06-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-165K
$150.00
-25M
1
$27.14B
2020-06-02
2020-06-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
165K
$13.00
2.14M
2
$27.14B
2020-06-02
2020-06-04
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-165K
$0.00
2
$27.14B
2020-06-01
2020-06-03
BOUSBIB ARI
Chairman, Chief Executive Offi...
A - Grant
Common Stock
19,443
$15.00
292K
1
$27.14B
2020-06-01
2020-06-03
BOUSBIB ARI
Chairman, Chief Executive Offi...
X - Exercise
Employee Stock Option (Right to Buy)
-19,443
$0.00
1
$27.14B
2020-06-01
2020-06-03
BOUSBIB ARI
Chairman, Chief Executive Offi...
S - Sale
Common Stock
-19,443
$150.00
-2.92M
1
$27.14B
2020-03-24
2020-03-26
EVANISKO MICHAEL
M - Exercise
Employee Stock Option (right to buy)
6,600
$0.00
1
$27.14B
2020-03-03
2020-03-05
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-259
$141.00
-36,519
1
$27.14B
2020-02-21
2020-02-25
KNIGHTLY KEVIN
President, Technology & Commer...
S - Sale
Common Stock
-2,191
$163.00
-357K
1
$27.14B
2020-02-19
2020-02-20
KNIGHTLY KEVIN
President, Technology & Commer...
S - Sale
Common Stock
-5,688
$165.00
-939K
1
$27.14B
2020-02-18
2020-02-20
STAUB RICHARD
President, Research & Developm...
M - Exercise
Common Stock
18,224
$78.00
1.42M
1
$27.14B
2020-02-18
2020-02-20
STAUB RICHARD
President, Research & Developm...
D - Sale to Issuer
Common Stock
-8,674
$165.00
-1.43M
1
$27.14B
2020-02-18
2020-02-20
STAUB RICHARD
President, Research & Developm...
M - Exercise
Stock Appreciation Right
-18,224
$0.00
1
$27.14B
2020-02-18
2020-02-20
STAUB RICHARD
President, Research & Developm...
S - Sale
Common Stock
-14,550
$164.00
-2.39M
1
$27.14B
2020-02-13
2020-02-18
TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
S - Sale
Common Stock
-3.00M
$164.00
-491M
1
$27.14B
2020-02-11
2020-02-13
KNIGHTLY KEVIN
President, Technology & Commer...
F - Tax
Common Stock
-3,222
$162.00
-522K
1
$27.14B
2020-02-11
2020-02-13
STAUB RICHARD
President, Research & Developm...
F - Tax
Common Stock
-3,081
$162.00
-499K
1
$27.14B
2020-02-11
2020-02-13
SHERBET ERIC
Executive Vice President, Gene...
A - Grant
Stock Appreciation Right
22,404
$0.00
1
$27.14B
2020-02-11
2020-02-13
BOUSBIB ARI
Remarks: Chairman, Chief Exec...
A - Grant
Common Stock
76,374
$0.00
1
$27.14B
2020-02-11
2020-02-13
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Stock Appreciation Right
14,936
$0.00
1
$27.14B
2020-02-11
2020-02-13
KNIGHTLY KEVIN
President, Technology & Commer...
A - Grant
Common Stock
8,910
$0.00
1
$27.14B
2020-02-11
2020-02-13
KORAKIS EMMANUEL
Sr. Vice President, Controller
A - Grant
Stock Appreciation Right
5,974
$0.00
1
$27.14B
2020-02-11
2020-02-13
MCDONNELL MICHAEL
EVP and CFO
A - Grant
Stock Appreciation Right
23,897
$0.00
1
$27.14B
2020-02-11
2020-02-13
BOUSBIB ARI
Remarks: Chairman, Chief Exec...
A - Grant
Stock Appreciation Right
224K
$0.00
1
$27.14B
2020-02-11
2020-02-13
STAUB RICHARD
President, Research & Developm...
A - Grant
Stock Appreciation Right
22,404
$0.00
1
$27.14B
2020-02-11
2020-02-13
STAUB RICHARD
President, Research & Developm...
A - Grant
Common Stock
8,910
$0.00
1
$27.14B
2020-02-11
2020-02-13
BOUSBIB ARI
Remarks: Chairman, Chief Exec...
F - Tax
Common Stock
-37,401
$162.00
-6.06M
1
$27.14B
2020-02-02
2020-02-04
BOUSBIB ARI
Remarks: Chairman, Chief Exec...
F - Tax
Common Stock
-30,201
$155.00
-4.68M
1
$27.14B
2020-01-31
2020-02-04
EVANISKO MICHAEL
M - Exercise
Employee Stock Option (right to buy)
-6,250
$0.00
1
$27.14B
2020-01-24
2020-01-28
EVANISKO MICHAEL
M - Exercise
Employee Stock Option (right to buy)
-6,250
$0.00
2
$27.14B
2020-01-17
2020-01-21
EVANISKO MICHAEL
M - Exercise
Employee Stock Option (right to buy)
-6,250
$0.00
1
$27.14B
2020-01-10
2020-01-14
EVANISKO MICHAEL
M - Exercise
Employee Stock Option (right to buy)
-6,250
$0.00
1
$27.14B
2019-12-31
2020-01-03
BOUSBIB ARI
Remarks: Chairman, Chief Exec...
F - Tax
Common Stock
-86,874
$155.00
-13M
1
$27.14B
2019-12-20
2019-12-26
LEONARD JOHN
M - Exercise
Employee Stock Option (Right to Buy)
-20,200
$0.00
3
$27.14B